-
assignment_indナノキャリアについて事業内容The Company is a Japan-based biopharmaceutical products developer. The Company is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The Company's product candidates include Paclitaxel Micelle for the treatment of stomach cancer, Nanoplatin for the treatment of pancreatic cancer, and DACH-Platin Micelle for the treatment of solid cancer. The Company was established on June 14, 1996. Its share was listed on the Tokyo Stock Exchange Mothers on March 5, 2008.証券コード市場・商品区分マザーズ（内国株）業種医薬品規模区分Webサイト
-
commentこの開示に対するコメント（3 件）
ナノIR https://t.co/xLP9t6MTJO baizou (@baizou) 2016, 01月 08
@tadataru 中途半端な時間にポジティブ開示がｗ https://t.co/MfJCWiSwNh ぼーず (@yosh_yok) 2016, 01月 08
ナノキャリア、NC-6004ナノプラチン 米国で頭頸部がんを対象とした第I/II相臨床試験開始 https://t.co/piN6UBRCpg 岡三マン (@okasanman) 2016, 01月 08
Retweeted by
-
language関連サイト（0 件）